MetaCap

Nuvation Bio Statistics

NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.80-0.01 (-0.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Nuvation Bio by the numbers

Nuvation Bio has a market capitalization of $1.34 billion based on 352.02M shares outstanding. With trailing EPS of $-0.39, Nuvation Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.9% below its 50-day average and 28.0% below its 200-day average.

Average daily trading volume is 5.24M shares, or about $19.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NUVB valuation vs. peer median

NUVB compared with the median of 8 peer companies
MetricNUVBPeer medianDifference
Market cap$1.34B$1.36B-1%
Avg. volume5.24M821.59K+538%

Peer median across 8 companies: NBTX, PAHC, URGN, QURE, RAPP, INVA, ANAB, TYRA.

Valuation

Price / sales (latest FY)
21.33
EPS (TTM)
$-0.39

Price and trading

Previous close
3.81
Open
3.77
Day range
3.72 – 3.91
52-week range
3.71 – 9.75
52-week change
-45.64%
Beta
—
Volume
6.85M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.34B
Forward Pe
-47.50
Eps
-0.39
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
9.75
Week52 Low
3.71
Avg Volume
5.24M
Shares Outstanding
352.02M
Ma50
4.87
Ma200
5.28
Earnings Date
Nov 4, 2026
Pct From52w High
-61.03%
Pct From52w Low
2.43%

Related